Followers | 25 |
Posts | 2198 |
Boards Moderated | 0 |
Alias Born | 10/30/2014 |
Friday, October 06, 2017 9:31:47 AM
Capital requirements
To the extent that the cash flow from operations are insufficient to fund the Company’s operations, we will be required to raise additional capital through equity or debt financing. Any additional equity financing may be dilutive to shareholders, and debt financing, if available, may involve significant restrictive covenants. The Company’s failure or inability to raise capital when needed could have a material adverse effect on the Company’s business, financial condition and results of operations. There can be no assurance that such financing will be available on terms satisfactory to the Company, if at all.
The Company may conduct further offerings in the future, in which case your shareholdings will be diluted
The Company may rely on equity sales of common stock to fund operations. The Company may conduct further equity and/or convertible debt offerings in the future to finance operations or other projects that it decides to undertake. If common stock is issued in return for additional funds, or upon conversion or exercise of outstanding convertible debentures or warrants, the price per share could be lower than that paid by existing common stockholders. The Company anticipates continuing to rely on equity sales of common stock and issuances of convertible debt and/or warrants convertible or exercisable into shares of common stock in order to fund its business operations. If the Company issues additional shares of common stock, your percentage interest in the Company will be lower. This condition, often referred to as “dilution”, could result in a reduction in the per share value of your shares of common stock.
obviously some heavy diluting going on and OMVS/RAd refuses to be transparent and has gagged the Transfer Agent to mask the dilution, while investors must wait until financials to see the extent of dilution and toxic funding to come....
If only the CEO has chosen to go the route of transparency,future investors now will be very hard to come by and rely on information put forth by tweets
Recent AITX News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/24/2024 10:02:02 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/23/2024 10:05:20 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/23/2024 10:00:15 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/19/2024 10:05:22 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/16/2024 10:07:07 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/04/2024 10:06:29 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/03/2024 10:03:51 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/26/2024 10:03:30 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/21/2024 10:03:32 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/19/2024 10:08:57 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/15/2024 10:10:43 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 10:10:47 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 10:03:44 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 10:03:06 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2024 10:03:34 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/05/2024 10:04:05 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 10:16:27 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/30/2024 10:10:15 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/23/2024 10:04:54 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/19/2024 10:05:21 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/18/2024 08:22:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/16/2024 10:03:31 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/15/2024 08:00:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/15/2024 10:07:42 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/11/2024 10:04:29 AM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM